Facilitating Innovations and Therapies that Improve Clinical Outcomes

If you have lately been occupied about therapies you could develop, medical devices, protocols, and systems you could improve for better patient care and clinical outcome but:

Are unsure of how to or where to start?

Do not have the time or resources to do so?

Are unsure how to limit risks, missteps,

liabilities in the development process?

Do not know where to obtain proper guidance

and industry insights?

Certa Victoria Scientific Guides Innovative Ideas to Success

Many beautiful ideas die at inception. Don’t let yours be one of them.

CLICK TO LEARN ABOUT OUR

VIABLE INNOVATIONS PROGRAM

About Us

Certa Victoria Scientific provides healthcare industry advisory, high value counsel on medical products/services development and commercialization.

Our Mission:

To accelerate the development of innovations and therapies that improve patient care and clinical outcomes.

Our Vision:

To fully rekindle Innovation amongst Physicians and Scientists. We aim to reactivate the Genius Mindset in Our Best Intellects.

We believe case studies and research should not only be about white papers and articles, or exercises aimed towards completion of academic requirements, but a sincere effort directed towards finding solutions to many challenges that plague our world. Therefore, we help our clients analyze their idea’s viability and potential applications to real-world issues and guide them to actualize it.

LEARN MORE

Client Product Highlight

Pertinent Issue:

SEPSIS

Life-threatening organ dysfunction caused by a dysregulated host response to infection.

Synopsis:

Sepsis is a leading cause of mortality and critical illness worldwide. Approximately 30% of patients diagnosed with severe sepsis do not survive.

During this COVID-19 pandemic, prior to COVID-19 Vaccination, an average of about 70% of COVID-19 patients requiring ICU care had septic shock severe enough to require cardiovascular support which racks up cost of care. The risk of dying from sepsis increases by as much as 8% for every hour treatment is delayed. Sepsis accounts for $100 billion in annual hospital cost; the most expensive condition to treat in the entire U.S. healthcare system.

Proffered Solution:

Prevent fatalities by Accurate Sepsis Prediction, Early Sepsis Recognition and Rapid Treatment.

Client Product:

Morley Medical Sepsis Risk Mitigation Tool

Morley Medical Sepsis Risk Mitigation Tool is a Predictive Analytics and Risk Assessment Software System that uses a unique AI powered machine learning algorithms to proactively monitor real time the risk of a patients developing sepsis in a clinical setting and generate clinical decision support output for physicians. Morley Medical Sepsis Risk Mitigation Tool has the highest predictive accuracy (95.4%) and sensitivity (98.5%) for sepsis when compared with any other risk mitigation tool.

Clinical Success:

Our client hospitals using Morley Medical Sepsis Risk Mitigation Tool in addition to reducing sepsis associated mortality and morbidity, reports about 60% reduction in sepsis associated cost and non-reimbursable expenses due to sepsis, a saving ranging from $10 Million to over $100 Million depending on hospital size and prevailing number of sepsis cases.

Reduce Sepsis MORTALITY AND ASSOCIATED COSTS

To Integrate Morley Medical Sepsis Risk Mitigation Tool into your Hospital EHR